Перейти к содержанию

MiniMed Group, Inc. (MMED) stock: revenue, earnings & dividend

MiniMed Group, Inc. (MMED, Nasdaq): revenue, earnings, dividend and balance sheet from official SEC filings.

Stock screener MMED · Nasdaq Medizintechnik & Messgeräte US-CA

Key figures

Fiscal year
2025
Revenue
3.1 bn $
Revenue growth
14.3 %
Revenue growth 5y (p.a.)
–
Net income
-333 m $
Net margin
-10.7 %
Operating margin
-6.1 %
Earnings per share (diluted)
-1.30 $
Dividend per share
–
Payout ratio
–
Consecutive dividend years
–
Consecutive dividend raises
–
Dividend growth 5y (p.a.)
–
Total assets
4.34 bn $
Equity
3.46 bn $
Equity ratio
79.7 %
Return on equity
-9.6 %
Cash
10 m $
Operating cash flow
-197 m $
Free cash flow
-420 m $
Shares outstanding
281,349,931

History

Revenue by fiscal year

2023 2.47 bn $
2024 2.72 bn $
2025 3.1 bn $

Net income by fiscal year

2023 -112 m $
2024 -213 m $
2025 -333 m $
YearRevenueNet incomeEPSDividend per shareOperating cash flow
20253.1 bn $-333 m $-1.30 $–-197 m $
20242.72 bn $-213 m $-0.84 $–140 m $
20232.47 bn $-112 m $-0.44 $–41 m $

Data from XBRL filings at the SEC, processed automatically, no guarantee. Not investment advice. All filings at the SEC (EDGAR)